Modulating mesenchymal stromal cell function with cholesterol synthesis inhibitors.

Poggi, A; Zocchi, M R

Poggi, A; Zocchi, M R.

Affiliation

Poggi A; Unit of Molecular Oncology and Angiogenesis, IRCCS AOU-San Martino-IST, National Institute for Cancer Research, Genoa, Italy. alessandro.poggi@istge.it

Curr Med Chem ; 18(34): 5196-205, 2011.

Article in En | MEDLINE | ID: mdl-22087820

Subject(s)

Anticholesteremic Agents/pharmacology; Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology; Mesenchymal Stem Cells/drug effects; Tumor Microenvironment/drug effects; Animals; Humans; Mesenchymal Stem Cells/pathology

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Hydroxymethylglutaryl-CoA Reductase Inhibitors / Tumor Microenvironment / Mesenchymal Stem Cells / Anticholesteremic Agents Limits: Animals / Humans Language: En Journal: Curr Med Chem Year: 2011 Document type: Article

Search on Google

XML

PubMed Links